NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History $2.03 +0.05 (+2.53%) (As of 12/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NeuroBo Pharmaceuticals Stock Price Performance 5 Day Performance+15.34%1 Month Performance-21.92%3 Month Performance-24.54%6 Month Performance-56.62%Year-To-Date Performance+2.53%1 Year Performance-52.12% Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol NRBO Stock Chart for Thursday, January, 2, 2025 NRBO Chart by TradingView NeuroBo Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/02/2025$2.03$2.03$2.17$2.00104,705 shs$17.49 million01/01/2025$1.98$2.03+2.53%$2.17$2.00104,705 shs$17.49 million12/31/2024$1.76$1.98+12.50%$2.05$1.76260,719 shs$17.06 million12/30/2024$1.76$1.76$1.81$1.6651,385 shs$15.16 million12/27/2024$1.62$1.81+11.73%$1.93$1.5594,558 shs$15.60 million12/26/2024$1.62$1.62$1.63$1.5530,180 shs$13.96 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/25/2024$1.63$1.62-0.61%$1.63$1.5530,180 shs$13.96 million12/24/2024$1.60$1.63+1.87%$1.67$1.5196,796 shs$14.04 million12/23/2024$1.60$1.60$1.78$1.60150,580 shs$13.79 million12/20/2024$1.85$1.76-4.86%$1.83$1.69129,623 shs$15.16 million12/19/2024$2.25$1.85-17.73%$2.10$1.554.88 million shs$15.94 million12/18/2024$2.21$2.25+1.75%$2.38$2.1722,650 shs$19.37 million12/17/2024$2.19$2.21+0.91%$2.50$2.1639,213 shs$19.04 million12/16/2024$2.19$2.19$2.38$2.1835,817 shs$18.87 million12/13/2024$2.31$2.31$2.48$2.3024,535 shs$19.86 million12/12/2024$2.26$2.31+1.99%$2.48$2.3024,535 shs$19.86 million12/11/2024$2.32$2.26-2.59%$2.41$2.1840,438 shs$19.47 million12/10/2024$2.31$2.32+0.43%$2.35$2.2416,246 shs$19.99 million12/09/2024$2.31$2.31$2.46$2.0422,488 shs$19.90 million12/06/2024$2.30$2.30$2.54$2.2830,286 shs$19.82 million12/05/2024$2.45$2.30-6.12%$2.54$2.2830,181 shs$19.82 million12/04/2024$2.57$2.45-4.67%$2.47$2.2827,154 shs$21.11 million12/03/2024$2.60$2.57-1.15%$2.64$2.3518,316 shs$22.14 million12/02/2024$2.55$2.60+1.96%$2.65$2.3340,276 shs$22.40 million Related Companies Shattuck Labs Stock Price Chart Xilio Therapeutics Stock Price Chart Reviva Pharmaceuticals Stock Price Chart Celularity Stock Price Chart Spero Therapeutics Stock Price Chart Exicure Stock Price Chart Iterum Therapeutics Stock Price Chart Fortress Biotech Stock Price Chart FibroGen Stock Price Chart Kezar Life Sciences Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredDeadline Approaching! A new system to collect up to $4,243 in monthly dividendsI've just released updated details on a new system for collecting steady dividend income each and every month....Investors Alley | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
